The anti-tumor angiogenesis mechanism entails the down-regulation of matrix metalloproteinases (MMP) (endogenous proteolytic enzyme), VEGF, COX-2, and angiotensin-2 (Huang and Wang, 2019). The gene discussed is PTGS2; the disease is neoplasm.